The U.S. Food and Drug Administration approved a generic version of Truvada, the only drug approved so far to use as pre-exposure prophylaxis, a prevention method known as PrEP, which when taken daily ...
The U.S. Food and Drug Administration has approved the first generic version of Truvada, a combination pill used for both HIV treatment and prevention, but it will not soon hit pharmacy shelves, ...
The US Food and Drug Administration (FDA) has approved a generic form of the drug Truvada, an antiretroviral and pre-exposure prophylaxis (PrEP) from Gilead Sciences. The approval notice was posted on ...
HHS has announced that Gilead will donate its pre-exposure prophylaxis (PrEP) pill Truvada for up to 200,000 people in a multiyear agreement, just a day after the pharma giant announced that a generic ...
Generic PrEP use could reduce new HIV acquisitions, save lives among young men who have sex with men
Anne Neilan, MD, a physician-scientist in the division of Infectious Diseases at Massachusetts General Hospital is the senior author of a recently published paper in Clinical Infectious Diseases, ...
Please provide your email address to receive an email when new articles are posted on . PrEP adherence and engagement continues to be an issue for young men who have sex with men. PrEP use among this ...
Anne Neilan, MD, a physician-scientist in the division of Infectious Diseases at Massachusetts General Hospital is the senior author of a recently paper titled "Daily Oral HIV Pre-exposure Prophylaxis ...
In a functioning market, low-cost generic versions of PrEP would be deemed vital to the country’s PrEP response, allowing for broad distribution. But this hasn’t happened. Pre-exposure prophylaxis or ...
About one in five new HIV diagnoses in the United States occur among youth ages 13 to 24 years. Young men who have sex with men (YMSM) are account for 81% of new diagnoses in this age group in 2019.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results